TrialNature communications2026

Adjunctive ibuprofen in pre-extensively drug-resistant and extensively drug-resistant tuberculosis: a phase IIA open-label pilot clinical trial.

Kaori L Fonseca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.